Read More Pharma Industry News Novartis to expand radiopharmaceuticals portfolio with $2.1bn Endocyte acquisition Swiss pharmaceutical company Novartis has announced a strategic acquisition of the US-based biopharma firm Endocyte for approximately $2.1… bypharmanewsdailyOctober 21, 2018